|
|
Volumn 118, Issue 1, 2002, Pages 347-
|
|
Analysis of durability of response to thalidomide treatment for relapsed myeloma patients [3]
a
|
|
Author keywords
Duration; Myeloma; Thalidomide; Therapy
|
|
Indexed keywords
DEXAMETHASONE;
PARAPROTEIN;
THALIDOMIDE;
ADULT;
AGE;
AGED;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RECURRENCE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRANIAL NERVE PARALYSIS;
DRUG RESPONSE;
DRUG TOLERANCE;
EDEMA;
FEMALE;
FOLLOW UP;
HUMAN;
HYPOTHYROIDISM;
KIDNEY FAILURE;
LETTER;
MALE;
MYELOMA;
PARESTHESIA;
PRIORITY JOURNAL;
RASH;
SENSORY NEUROPATHY;
TREATMENT OUTCOME;
TREMOR;
AGED;
AGED, 80 AND OVER;
DEXAMETHASONE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
RECURRENCE;
THALIDOMIDE;
|
|
EID: 0036069297
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03576_4.x Document Type: Letter |
|
Times cited : (3)
|
|
References (4)
|
